Rimonabant reduces weight and cardiovascular risk in overweight patients with diabetes

被引：0
|
作者：
不详
机构：
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2007年 / 3卷 / 3期
关键词：
D O I：
10.1038/ncpendmet0406
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：201 / 201
相关论文
共 50 条
  • [21] Effect of rimonabant on quality of life in overweight/obese patients
    Kolotkin, RL
    Crosby, RD
    Scheen, A
    Golay, A
    Després, JP
    VALUE IN HEALTH, 2006, 9 (03) : A92 - A92
  • [22] Effect of rimonabant on weight and cardiometabolic risk factors
    Gadde, Kishore M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (06): : 649 - 650
  • [23] Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
    Wing, Rena R.
    Lang, Wei
    Wadden, Thomas A.
    Safford, Monika
    Knowler, William C.
    Bertoni, Alain G.
    Hill, James O.
    Brancati, Frederick L.
    Peters, Anne
    Wagenknecht, Lynne
    DIABETES CARE, 2011, 34 (07) : 1481 - 1486
  • [24] Weight loss surgery and cardiovascular risk and mortality in patients with type 2 diabetes
    Pournaras, Dimitri J.
    Welbourn, Richard
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (11): : 828 - 829
  • [25] Rimonabant: A guide to its use in obese and overweight patients
    不详
    Drugs & Therapy Perspectives, 2007, 23 (8) : 5 - 8
  • [26] Cardiovascular Risk and HbA1c levels in overweight patients with Type 2 Diabetes
    Nowotny, B.
    DIABETOLOGE, 2012, 8 (07): : 581 - 582
  • [27] Exercise and weight loss effects on cardiovascular risk factors in overweight men
    Rosenkilde, Mads
    Rygaard, Lisbeth
    Nordby, Pernille
    Nielsen, Lars Bo
    Stallknecht, Bente
    JOURNAL OF APPLIED PHYSIOLOGY, 2018, 125 (03) : 901 - 908
  • [28] Overweight and cardiovascular risk
    Schulte, H
    von Eckardstein, A
    Cullen, P
    Assmann, G
    HERZ, 2001, 26 (03) : 170 - 177
  • [29] CARDIOVASCULAR RISK-FACTORS IN OBESITY - THE EFFECT OF WEIGHT-REDUCTION ON PLATELET SIZE IN OVERWEIGHT PATIENTS
    TOPLAK, H
    SAGMEISTER, E
    WASCHER, TC
    INTERNATIONAL JOURNAL OF OBESITY, 1994, 18 (05) : 355 - 356
  • [30] Rimonabant improves cardiometabolic risk factors in overweight/obese patients with type 2 diabetes irrespective of background oral antidiabetic therapy (metformin or sulfonylureas)
    Scheen, Andre
    Finer, Nick
    Hollander, Priscilla
    Van Gaal, Luc
    DIABETES, 2006, 55 : A133 - A134
12345